🇺🇸 FDA
Pipeline program

A drug-drug interaction trial in healthy female participants to investigate the effect of aprocitentan on combined hormonal contraceptives.

ID-080-111

Phase 1 other active

Quick answer

A drug-drug interaction trial in healthy female participants to investigate the effect of aprocitentan on combined hormonal contraceptives. for Not applicable - healthy volunteer trial is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Not applicable - healthy volunteer trial
Phase
Phase 1
Modality
other
Status
active

Clinical trials